Cargando…
Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
Autores principales: | Deng, Wei, Xu, Yanfeng, Kong, Qi, Xue, Jing, Yu, Pin, Liu, Jiangning, Lv, Qi, Li, Fengdi, Wei, Qiang, Bao, Linlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205908/ https://www.ncbi.nlm.nih.gov/pubmed/32385228 http://dx.doi.org/10.1038/s41392-020-0176-0 |
Ejemplares similares
-
Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
por: Kong, Qi, et al.
Publicado: (2020) -
Clinical efficacy evaluation and potential mechanism prediction on Pudilan Xiaoyan oral liquid in treatment of mumps in children based on meta-analysis, network pharmacology, and molecular docking
por: Liu, Yi, et al.
Publicado: (2022) -
Anti-Inflammatory Effects and Mechanisms of Pudilan
Antiphlogistic Oral Liquid
por: Tian, Gang, et al.
Publicado: (2021) -
The Effect of Pudilan Anti-Inflammatory Oral Liquid on the Treatment of Mild Recurrent Aphthous Ulcers
por: Jin, Ying, et al.
Publicado: (2017) -
Neurotropism In Vitro and Mouse Models of Severe and Mild Infection with Clinical Strains of Enterovirus 71
por: Yu, Pin, et al.
Publicado: (2017)